Join
Live feed
·
INSIDERFilingvia Quantisnow
Lixte Biotechnology Holdings Inc. logo

SEC Form 4: Bernards Rene bought $27,825 worth of shares (52,500 units at $0.53), increasing direct ownership by 72% to 125,000 units

ByQuantisnow·Wall Street's wire, on your screen.
LIXT· Lixte Biotechnology Holdings Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track LIXT (Lixte Biotechnology Holdings Inc.) and more on Quantisnow.